Zealand Pharma A (ZEAL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Zealand Pharma A.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ZEAL's average price target has moved up $1.13 over the prior 28 days.
Over the past 183 days, ZEAL's average upside potential has been 22.32%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ZEAL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 92 days, ZEAL's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZEAL as an investment opportunity.
- The number of analysts covering the stock of ZEAL is higher than 96.38% of stocks in the small market cap category.
- The average analyst price target of ZEAL is greater than 83.68% of stocks in the small market cap category.
- ZEAL has a less variance in analysts' estimates than 24.38% of stocks in the small market cap category.
- ZEAL has a higher upside potential (average analyst target price relative to current price) than 25.18% of Pharmaceutical Products stocks.
Is ZEAL a Buy, Hold or Sell? See the POWR Ratings now!